Does TOCILIZUMAB Cause Nasopharyngitis? 6,664 Reports in FDA Database

Q: Does TOCILIZUMAB cause Nasopharyngitis?

6,664 reports of Nasopharyngitis have been filed with the FDA for TOCILIZUMAB, representing 6.8% of all TOCILIZUMAB adverse event reports.

Q: How dangerous is Nasopharyngitis from TOCILIZUMAB?

Of 6,664 reports, 1,495 (22.4%) resulted in death and 2,909 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 6,664 reports of Nasopharyngitis have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 6.8% of all adverse event reports for TOCILIZUMAB.

6,664

Reports of Nasopharyngitis with TOCILIZUMAB

6.8%

of all TOCILIZUMAB reports

1,495

Deaths

2,909

Hospitalizations

How Dangerous Is Nasopharyngitis From TOCILIZUMAB?

Of the 6,664 reports, 1,495 (22.4%) resulted in death, 2,909 (43.7%) required hospitalization, and 1,563 (23.5%) were considered life-threatening.